Liberia

in page functions
[French]
Liberia
Total population (2016) 4,615,221
Birth cohort (2016) 158,427
Surviving Infants (surviving to 1 year per year, 2016) 149,743
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 53/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 70/1000
World Bank Index, IDA (2012) 2.92
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 15

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Liberia

Type of support

Approvals

2001-2021 (US$)
(21 Nov 2016)

Commitments

2001-2021 (US$)
(21 Nov 2016)

Disbursements

2000-2016 (US$)
(21 Nov 2016)

% Disbursed

(21 Nov 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $37,410,814 $48,636,814 $35,471,009
Cash Support (CASHSUPP) $198,500 $223,500 $198,500 100%
Ebola EPI Recovery Plan (EEPIRP) $2,811,269 $2,811,269 $2,811,269 100%
Health system strengthening (HSS 1) $3,689,254 $3,689,254 $3,689,254 100%
Health system strengthening (HSS 2) $4,680,000 $4,680,000 $3,240,000 69%
HPV Demo (NVS) $299,607 $299,607 $234,348 78%
Immunisation services support (ISS) $2,188,750 $2,188,750 $2,188,750 100%
Injection Safety Devices (NVS) $51,500 $246,000
Injection safety support (INS) $360,500 $360,500 $266,500 74%
IPV (NVS) $383,693 $383,693 $13,410 3%
Penta (NVS) $10,700,808 $13,261,808 $11,308,989 106%
Pneumo (NVS) $7,712,683 $13,410,683 $7,856,100 102%
Rotavirus (NVS) $1,628,941 $3,807,941 $1,010,941 62%
Vaccine Introduction Grant (VIG) $619,000 $619,000 $619,000 100%
Yellow Fever (NVS) $2,086,308 $2,654,808 $2,033,948 97%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Liberia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 65%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2012) 69.20%
Household survey: DTP3 coverage for female (2012) 73.80%
Household survey: Last DTP3 survey (2012) 71%
% districts achieving > 80% DTP3 coverage (2015) 20%
% districts achieving < 50% DTP3 coverage (2015) 7%
MCV WHO/UNICEF estimates (2015) 64%

Breakdown of support

Non-vaccine support Vaccine support
37% 63%
$13,013,273 $22,457,733

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Liberia

02 November 2016

liberia-girls-HPV-vaccination-card

New Lancet figures show vaccine could save 600,000 women's lives from cervical cancer

Study warns that without urgent action cases could rise by 25% by 2030.

18 October 2016

HPV vaccinations in Liberia 2016

Not every girl goes to school everyday in Liberia, West Africa. So if you want to improve coverage of the HPV vaccination in ten year old girls, sometimes you have to take it to the streets.

11 October 2016

Feature 1 HPV bg

Preventing cervical cancer: out-of-school lessons learnt

To date, immunisation against human papillomavirus (HPV), which helps prevent cervical cancer, has largely been conducted through school-based campaigns. But what about those who do not go to school? How do we reach communities where there is low school attendance? A new, more community- orientated approach being tested in Bong County, Liberia, may provide the answer to these questions.

close icon

modal window here